Atlas Trials

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Clinical trial NCT05827549 · RECRUITING

Trial details

NCT number
NCT05827549
Sponsor
Ho Joon Im
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoid Leukemia
Start date
2024-04-04
Primary completion
2032-12-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.